Aspirin has potential benefits for primary prevention of cardiovascular outcomes in diabetes: updated literature-based and individual participant data meta-analyses of randomized controlled trials

被引：0
|
作者：
Samuel Seidu
Setor K. Kunutsor
Howard D. Sesso
J. M. Gaziano
J. E. Buring
Maria Carla Roncaglioni
Kamlesh Khunti
机构：
[1] Leicester Diabetes Centre,Diabetes Research Centre
[2] Leicester General Hospital,National Institute for Health Research Bristol Biomedical Research Centre
[3] University of Leicester,Translational Health Sciences, Bristol Medical School, Musculoskeletal Research Unit
[4] Leicester General Hospital,Division of Preventive Medicine
[5] University Hospitals Bristol NHS Foundation Trust and University of Bristol,Department of Medicine, Division of Aging
[6] University of Bristol,undefined
[7] Brigham and Women’s Hospital,undefined
[8] Brigham and Women’s Hospital,undefined
[9] Istituto di Ricerche Farmacologiche Mario Negri-IRCCS,undefined
来源：
Cardiovascular Diabetology | / 18卷
关键词：
Aspirin; Diabetes; Primary prevention; Cardiovascular disease; All-cause mortality; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Associations between statins and adverse events in secondary prevention of cardiovascular disease: Pairwise, network, and dose-response meta-analyses of 47 randomized controlled trials
    Wang, Xinyi
    Li, Jingen
    Wang, Tongxin
    Zhang, Zihao
    Li, Qiuyi
    Ma, Dan
    Chen, Zhuo
    Ju, Jianqing
    Xu, Hao
    Chen, Keji
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [42] Efficacy and Moderators of Internet-Based Interventions in Adults with Subthreshold Depression: An Individual Participant Data Meta-Analysis of Randomized Controlled Trials
    Reins, Jo Annika
    Buntrock, Claudia
    Zimmermann, Johannes
    Grund, Simon
    Harrer, Mathias
    Lehr, Dirk
    Baumeister, Harald
    Weisel, Kiona
    Domhardt, Matthias
    Imamura, Kotaro
    Kawakami, Norito
    Spek, Viola
    Nobis, Stephanie
    Snoek, Frank
    Cuijpers, Pim
    Klein, Jan Philipp
    Moritz, Steffen
    Ebert, David Daniel
    PSYCHOTHERAPY AND PSYCHOSOMATICS, 2021, 90 (02) : 94 - 106
  • [43] Cardiovascular safety of the glucagon-like peptide-1 receptor agonist taspoglutide in people with type 2 diabetes: an individual participant data meta-analysis of randomized controlled trials
    Seshasai, S. R. K.
    Bennett, R. L.
    Petrie, J. R.
    Bengus, M.
    Ekman, S.
    Dixon, M.
    Herz, M.
    Buse, J. B.
    Ray, K. K.
    DIABETES OBESITY & METABOLISM, 2015, 17 (05): : 505 - 510
  • [44] Cardiovascular outcomes of SGLT-2 inhibitors' subtypes in type 2 diabetes; an updated systematic review and meta-analysis of randomized controlled trials
    Ebrahimi, Pouya
    Soleimani, Hamidreza
    Mahalleh, Mehrdad
    Farisi, Pegah
    Taheri, Maryam
    Ramezani, Pedram
    Soltani, Parnian
    Nazari, Roozbeh
    Senobari, Nahid
    Mousavinezhad, Seyedeh Maryam
    Payab, Moloud
    Gooshvar, Mehrdad
    Zadeh, Amin Zaki
    Hosseini, Kaveh
    Ebrahimpur, Mahbube
    JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2025, 24 (01)
  • [45] The prevention and improvement effects of vitamin D on type 2 diabetes mellitus: evidence from an umbrella review on Meta-analyses of cohort studies and randomized controlled trials
    Cheng, Le
    Lv, Chenhui
    Xue, Lushan
    Zhang, Cheng
    Wang, Lili
    Wang, Xi
    Chen, Shuangzhi
    Li, Xuemin
    Feng, Wenjuan
    Xie, Haoran
    Zhao, Haifeng
    FRONTIERS IN NUTRITION, 2024, 11
  • [46] Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials
    Zoungas, Sophia
    Arima, Hisatomi
    Gerstein, Hertzel C.
    Holman, Rury R.
    Woodward, Mark
    Reaven, Peter
    Hayward, Rodney A.
    Craven, Timothy
    Coleman, Ruth L.
    Chalmers, John
    LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (06): : 431 - 437
  • [47] Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men - A meta-analysis of individual patient data from randomized, controlled trials
    Gueyffier, F
    Boutitie, F
    Boissel, JP
    Pocock, S
    Coope, J
    Cutler, J
    Ekbom, T
    Fagard, R
    Friedman, L
    Perry, M
    Prineas, R
    Schron, E
    ANNALS OF INTERNAL MEDICINE, 1997, 126 (10) : 761 - +
  • [48] Systematic review and individual participant data meta-analysis of randomized controlled trials assessing mindfulness-based programs for mental health promotion
    Julieta Galante
    Claire Friedrich
    Tim Dalgleish
    Peter B. Jones
    Ian R. White
    Nature Mental Health, 2023, 1 (7): : 462 - 476
  • [49] Effects of blood pressure-lowering treatment on cardiovascular outcomes andmortality: 13-benefits and adverse events in older and younger patients with hypertension: overview, meta-analyses and meta-regression analyses of randomized trials
    Thomopoulos, Costas
    Parati, Gianfranco
    Zanchetti, Alberto
    JOURNAL OF HYPERTENSION, 2018, 36 (08) : 1622 - 1636
  • [50] Ocriplasmin for treatment of vitreomacular traction and macular hole: A systematic literature review and individual participant data meta-analysis of randomized, controlled, double-masked trials
    Jackson, Timothy L.
    Haller, Julia
    Blot, Koenraad H.
    Duchateau, Luc
    Lescrauwaet, Benedicte
    SURVEY OF OPHTHALMOLOGY, 2022, 67 (03) : 697 - 711
12345